Preemptive Strike With Bortezomib in Multiple Myeloma Patients
NCT00657553
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
10
Enrollment
OTHER
Sponsor class
Stopped
Due to poor accrual
Conditions
Multiple Myeloma
Interventions
DRUG:
Bortezomib
Sponsor
University of Arkansas